Literature DB >> 2223575

Production and response of a human prostatic cancer line to transforming growth factor-like molecules.

A MacDonald1, G D Chisholm, F K Habib.   

Abstract

Serum-free media conditioned by the androgen insensitive human prostate cancer cell line DU145 showed immunological transforming growth factor-alpha (TGF alpha) activity, as well as competing activity in epidermal growth factor (EGF) radioreceptor assays (RRA). Furthermore, there were factors in the conditioned media which inhibited and stimulated DNA synthesis by DU145 cells in a dose-dependent fashion. Fractionation of the concentrated conditioned media by reverse-phase high performance liquid chromatography revealed several peaks containing EGF-like competitive activity only one of which demonstrated TGF alpha activity. However, none of the peaks corresponded to immunoreactive EGF. Measurement of EGF receptors on DU145 cells by competition and saturation analysis revealed high levels of receptors (mean +/- s.d. = 2.5 +/- 1 x 10(5) surface receptors per cell) which were of high affinity (Kd +/- s.d. = 1.0 +/- 0.5 nmol l-1). Although DU145 cells express high levels of EGF receptors, DNA synthesis was only minimally affected by exogenous EGF and TGF alpha.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223575      PMCID: PMC1971489          DOI: 10.1038/bjc.1990.333

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Loss of epidermal growth factor requirement and malignant transformation.

Authors:  P V Cherington; B L Smith; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

4.  Transforming growth factors: sources, properties and possible roles in normal and malignant cell growth control.

Authors:  K D Brown; D M Blakeley
Journal:  Biochem Soc Trans       Date:  1984-04       Impact factor: 5.407

5.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

6.  Autocrine secretion and malignant transformation of cells.

Authors:  M B Sporn; G J Todaro
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

7.  Anchorage-independent growth-conferring factor production by rat mammary tumor cells.

Authors:  J A Zwiebel; M R Davis; E Kohn; D S Salomon; W R Kidwell
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

8.  Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells.

Authors:  J Massagué
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

9.  Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor.

Authors:  H Marquardt; M W Hunkapiller; L E Hood; D R Twardzik; J E De Larco; J R Stephenson; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line.

Authors:  J M Connolly; D P Rose
Journal:  Prostate       Date:  1989       Impact factor: 4.104

View more
  11 in total

1.  Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.

Authors:  Soha Salama El Sheikh; Jan Domin; Paul Abel; Gordon Stamp; El-Nasir Lalani
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

Review 2.  Growth factors as mediators of androgen action during the development of the male urogenital tract.

Authors:  G R Cunha; B Foster; A Thomson; Y Sugimura; N Tanji; M Tsuji; N Terada; P W Finch; A A Donjacour
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

3.  SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.

Authors:  Lieven Huang; Lea Olive Tchouate Gainkam; Vicky Caveliers; Chris Vanhove; Marleen Keyaerts; Patrick De Baetselier; Axel Bossuyt; Hilde Revets; Tony Lahoutte
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

Review 4.  Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate.

Authors:  E R Sherwood; C Lee
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

5.  Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1.

Authors:  S W Hayward; R Dahiya; G R Cunha; J Bartek; N Deshpande; P Narayan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

6.  Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment.

Authors:  J E Damber; A Bergh; B Assarsson; M Gåfvels
Journal:  Urol Res       Date:  1995

7.  Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells.

Authors:  G J Rabiasz; S P Langdon; J M Bartlett; A J Crew; E P Miller; W N Scott; J F Smyth; W R Miller
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

8.  An enhanced and sensitive autocrine stimulation by transforming growth factor-alpha is acquired in the brain metastatic variant of a human non-small-cell lung cancer cell line.

Authors:  K Fang
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

9.  Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.

Authors:  Y Yang; G D Chisholm; F K Habib
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

10.  Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines.

Authors:  A MacDonald; F K Habib
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.